Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
European Archives of Psychiatry and Clinical Neuroscience|May 4, 2005
Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic reviewMazda Adli, Christopher Baethge, Andreas Heinz, et al.
Brain and Cognition|September 30, 2021
Memory enhancement with stimulants: Differential neural effects of methylphenidate, modafinil, and caffeine. A pilot studyLucas C Adam, Dimitris Repantis, Boris N Konrad, et al.
Neuron|September 18, 2024
Implications of the novel EU AI Act for neurotechnologiesChristoph Bublitz, Fruzsina Molnár-Gábor, Surjo R Soekadar
Psychological Medicine|April 1, 2026
Post-traumatic stress disorder symptoms following psychedelic use: a naturalistic survey studyRicarda Evens, Abdo Uyar, Emily Gosslau, et al.
Physiology & Behavior|September 1, 2015
Feeling smart: Effects of caffeine and glucose on cognition, mood and self-judgmentSusann Ullrich, Yfke C de Vries, Simone Kühn, et al.
Pharmacopsychiatry|June 9, 2016
Doxazosin, an α-1-adrenergic-receptor Antagonist, for Nightmares in Patients with Posttraumatic Stress Disorder and/or Borderline Personality Disorder: a Chart ReviewStefan Roepke, Heidi Danker-Hopfe, Dimitris Repantis, et al.
Neuroethics|February 21, 2022
Forensic Brain-Reading and Mental Privacy in European Human Rights Law: Foundations and ChallengesSjors Ligthart, Thomas Douglas, Christoph Bublitz, et al.
Frontiers in Psychiatry|November 17, 2022
Study protocol for "MDMA-assisted therapy as a treatment for major depressive disorder: A proof of principle study"Tor-Morten Kvam, Ivar W Goksøyr, Lowan H Stewart, et al.
Psychopharmacology|June 10, 2026
Attitudes and perceptions of psychedelic therapy among clinical trial participants with alcohol use disorder: a mixed-method studyJulian Kirsch, Christopher Poppe, Anne Beck, et al.
Journal of Law and the Biosciences|August 13, 2021
Is the European Data Protection Regulation sufficient to deal with emerging data concerns relating to neurotechnology?Stephen Rainey, Kevin McGillivray, Simi Akintoye, et al.
Pageof 5